NASDAQ: ACER Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Acer Therapeutics Inc.
November 04, 2019 at 13:15 PM EST
San Diego, CA -- (SBWIRE) -- 11/04/2019 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Acer Therapeutics Inc.
